- Home
- MKDW vs APLT Comparison
MKDW vs APLT Comparison
Compare MKDW & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKDW
- APLT
- Stock Information
- Founded
- MKDW 2006
- APLT 2016
- Country
- MKDW Taiwan
- APLT United States
- Employees
- MKDW N/A
- APLT N/A
- Industry
- MKDW
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- MKDW
- APLT Health Care
- Exchange
- MKDW NYSE
- APLT Nasdaq
- Market Cap
- MKDW 32.3M
- APLT 37.5M
- IPO Year
- MKDW N/A
- APLT 2019
- Fundamental
- Price
- MKDW $0.28
- APLT $0.37
- Analyst Decision
- MKDW
- APLT Buy
- Analyst Count
- MKDW 0
- APLT 7
- Target Price
- MKDW N/A
- APLT $6.10
- AVG Volume (30 Days)
- MKDW 13.9M
- APLT 2.3M
- Earning Date
- MKDW 12-31-2024
- APLT 04-14-2025
- Dividend Yield
- MKDW N/A
- APLT N/A
- EPS Growth
- MKDW N/A
- APLT N/A
- EPS
- MKDW N/A
- APLT N/A
- Revenue
- MKDW $3,670,722.00
- APLT $455,000.00
- Revenue This Year
- MKDW N/A
- APLT $3,031.87
- Revenue Next Year
- MKDW N/A
- APLT $312.01
- P/E Ratio
- MKDW N/A
- APLT N/A
- Revenue Growth
- MKDW 16.40
- APLT N/A
- 52 Week Low
- MKDW $0.17
- APLT $0.30
- 52 Week High
- MKDW $16.00
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- MKDW N/A
- APLT 42.55
- Support Level
- MKDW N/A
- APLT $0.31
- Resistance Level
- MKDW N/A
- APLT $0.38
- Average True Range (ATR)
- MKDW 0.00
- APLT 0.05
- MACD
- MKDW 0.00
- APLT 0.00
- Stochastic Oscillator
- MKDW 0.00
- APLT 48.39
About MKDW MKDWELL TECH INC
MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.